Vl. Dillonbader et al., RESULTS OF A CEFTRIAXONE-TO-CEFTIZOXIME SWITCH PROGRAM FOR TX OF UNCOMPLICATED COMMUNITY-ACQUIRED PNEUMONIA, Formulary, 31(3), 1996, pp. 221
Using data from two Small community hospitals (less than 200 beds) in
the Kansas City area, we conducted a retrospective evaluation of two t
hird-generation cephalosporins (ceftizoxime and ceftriaxone) used to t
reat 149 patients with uncomplicated community-acquired pneumonia. Our
hypothesis was that the therapeutic interchange of ceftizoxime for ce
ftriaxone would generate substantial cost savings without affecting ou
tcomes in mortality, morbidity, or length of stay. In this article, we
report our experiences.